Clinical Trial Update: Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dexamethasone for treating severe hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Nantes University Hospital | Conditions: Hospital Acquired Pneumonia | Phase 3 | Status: RECRUITING